ArticleFrontiers in immunology2025
Partial depletion of circulating neutrophil granulocytes in mice exacerbates the inflammatory response and hypothermia during LPS induced severe systemic inflammation.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- NLR and Platelet Dynamics: Simple, Cost-effective Biomarkers for Stratifying Severity in Acute Pancreatitis.Medical journal of the Islamic Republic of Iran · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: During acute inflammation, immune-to-brain signaling plays a pivotal role in the generation of sickness responses such as fever or hypothermia. Neutrophil granulocytes (NG) are a crucial component of the immune system and modulate inflammation. Moreover, neutropenic fever is a severe condition for immunocompromised patients that can be life threatening. Using a mouse model of partial NG depletion, we aimed to investigate how neutropenia alters immune-to-brain signaling and the development of sickness responses during high-dose-LPS-induced inflammation. Methods: To deplete NGs, mice were injected intraperitoneally (IP) with heterologous anti-polymorphonuclear leukocyte serum at 1:4 ratio in PBS (PMN, 1.82 mg/kg IgG) or normal rabbit serum (NRS, 1 mg/kg IgG) as a control. To induce inflammation, mice were injected IP with lipopolysaccharide (LPS, 2.5 mg/kg) or PBS as a control 24 h after PMN or NRS. Physiological parameters were documented using a telemetric system that continuously recorded: food and water intake, locomotor activity, and core body temperature. At 4 h or 24 h after LPS-stimulation, brain and serum samples were collected and analyzed for peripheral and brain inflammatory markers. Results: After stimulation with LPS, PMN-pretreated mice showed neutropenia (significantly by ~25% of the control value) and attenuated NG recruitment to the brain in a structure dependent manner. LPS-induced hypothermia was more severe in PMN-pretreated mice while other physiological parameters were only altered by LPS alone. Additional analyses in NG depleted mice revealed that corticosterone levels showed an early reduced but late increased magnitude, and circulating cytokines like interleukin-10 were exacerbated during LPS-induced inflammation. Despite a weak overall impact on the brain, the hypothalamus of neutropenic mice presented exacerbated LPS-induced levels of IL-6, a key mediator of inflammation, compared to immunocompetent control mice. Discussion: Overall, we found that partial NG depletion exaggerates the peripheral inflammatory response and this strong peripheral reaction may contribute to the exacerbation of sickness symptoms most likely involving circulating IL-10 with strong implications for clinical cases of neutropenic patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.